Trendlines Group Ltd is an Israel-based life sciences innovation commercialization company, which invents, discovers, invests in, partners and incubates innovation based medical and agricultural technologies. It invests principally through four business units: two Israeli government-franchised incubators, Trendlines Medical and Trendlines Agtech, a Singapore incubator, Trendlines Medical Singapore, and an in-house innovation center, Trendlines Labs. The Groupâ s portfolio include more than 50 companies engaged with medical and agricultural technologies and products. The Group is involved in all aspects of its portfolio companies from technology development to business building. The Group in partnerships with entrepreneurs, investors, strategic players, inventors, and governments aims to improve the human condition.

Employees

Sector

Investment Management & Fund Operators

Calendar

2024-09-18 - Extraordinary Shareholders Meeting

More about the company

Quotes

Date	Price	Change	Volume
24-09-12	0.0600 $	+5.26%	1,207,600
24-09-11	0.0570 $	0.00%	248,200
24-09-10	0.0570 $	0.00%	443,700
24-09-09	0.0570 $	+1.79%	1,197,500
24-09-06	0.0560 $	-1.75%	204,000

Delayed Quote Singapore S.E., September 12, 2024 at 12:58 am EDT

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Delayed Singapore S.E. Other stock markets 12:58:08 2024-09-12 am EDT			5-day change	1st Jan Change
0.0600 ^SGD	+5.26%		+5.26%	-34.07%

Aug. 28	Trendlines Secures $1.5 Million Investment from Controlling Shareholder	MT
Aug. 27	Vensica Medical Ltd. announced that it expects to receive $0.128 million in funding from Librae Holdings Limited, The Trendlines Group Ltd.	CI

Capitalization	44.82M 58.43M	P/E ratio 2022	-3.58x	P/E ratio 2023	-1.72x
Enterprise value	43.35M 56.52M	EV / Sales 2022	25.1x	EV / Sales 2023	-3.08x
Free-Float	39.49%	Yield 2022 *	-	Yield 2023	-

Trendlines Secures $1.5 Million Investment from Controlling Shareholder	Aug. 27	MT
Vensica Medical Ltd. announced that it expects to receive $0.128 million in funding from Librae Holdings Limited, The Trendlines Group Ltd.	Aug. 26	CI
The Trendlines Net Attributable Profit Plummets 64% in H1	Aug. 08	MT
The Trendlines Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	Aug. 07	CI
Trendlines Group Updates on Proposed Share Subscription Deal, Portfolio Companies	Aug. 05	MT
Trendlines Group Raising SG$4.4 Million via Subscription Deals; Shares Surge 20%	Jul. 04	MT
The Trendlines Group Ltd. announced that it expects to receive SGD 4.596 million in funding	Jul. 03	CI
AgriG8 Pte Ltd. announced that it has received funding from The Trendlines Group Ltd., Better Bite Ventures	Jun. 09	CI
The Trendlines Group Receives Valid Acceptances and Excess Applications for 67.8 Million Rights Shares	May. 29	MT
Trendlines Group Grants CEO Stock Options	May. 07	MT
Trendlines Group Proposes Rights Issue to Raise SG$4.4 Million	Mar. 26	MT
Singapore Shares Recover at Market Close After Mid-Day Fall; IFAST's Shares Jump 5% as Profit Balloons 917% in Q4 2023	Feb. 22	MT
Trendlines’ Attributable Net Loss Widens in H2 2023; Portfolio Value Decreases	Feb. 22	MT

Trendlines : Insectta announces Grand Opening of Insect Biomaterial Extraction Pilot Plant	Nov. 29	PU
Trendlines : Limaca Medical Receives FDA 510(k) Clearance	23-09-11	PU
Trendlines : H1 2022 Unaudited Financial Results	22-08-10	PU
Trendlines : H12022 Unaudited Financial Results	22-08-10	PU
Trendlines : Phytolon closes $14.5 million Series A funding round	22-07-06	PU

The Trendlines Group Ltd. Stock

Equities

42T

IL0011328858

Investment Management & Fund Operators

Valuation: The Trendlines Group Ltd.

Chart: The Trendlines Group Ltd.

Latest news: The Trendlines Group Ltd.

Last Transcript: The Trendlines Group Ltd.

Analysts' recommendations: The Trendlines Group Ltd.

Press Releases: The Trendlines Group Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: The Trendlines Group Ltd.

Venture Capital

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

1 day	+5.26%
1 week	+5.26%
Current month	+9.09%
1 month	+15.38%
3 months	-1.64%
6 months	-28.57%
Current year	-34.07%

Director	Title	Age	Since
Haim Brosh CEO	Chief Executive Officer	57	13-12-31
Irit Shemesh Catz COO	Chief Operating Officer	-	-
Shahar Harari CTO	Chief Tech/Sci/R&D Officer	-	-

Manager	Title	Age	Since
Elka Nir BRD	Director/Board Member	63	15-10-14
Boon Ann Sin BRD	Director/Board Member	66	20-06-16
Nehama Ronen CHM	Chairman	63	22-06-05

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
THE TRENDLINES GROUP LTD.	+5.26%	+5.26%	-36.84%	-41.18%	44.82M
HERCULES CAPITAL, INC.	+0.75%	-0.90%	+15.41%	+12.64%	3B
UMBRA COMPANIES INC.	-.--%	-.--%	+17.33%	-29.60%	1.77B
HBM HEALTHCARE INVESTMENTS AG	-2.40%	-1.04%	-7.37%	-52.23%	1.38B
OCTOPUS TITAN VCT PLC	0.00%	0.00%	-19.86%	-39.89%	1.23B
MOLTEN VENTURES PLC	+0.25%	-0.25%	+63.97%	-63.62%	983M
VERUSA HOLDING	-3.16%	-15.53%	+87.35%	+536.40%	647M
CION INVESTMENT CORPORATION	-0.09%	-1.79%	+7.34%	-	617M
OCTOPUS APOLLO VCT PLC	0.00%	0.00%	-6.21%	-0.65%	530M
WOORI TECHNOLOGY INVESTMENT CO., LTD	-4.96%	-5.53%	+89.51%	-22.55%	367M
Average	-0.44%	-2.08%	+21.06%	+33.26%	1.06B
Weighted average by Cap.	-0.43%	-1.63%	+18.36%	+13.89%

	2022	2023
Net sales	2.37M 3.1M	-20.99M -27.36M
Net income	-14.48M -18.88M	-34M -44.32M
Net Debt	-3.1M -4.04M	-1.47M -1.91M